title: Adrenomedullin enhances invasion by trophoblast cell lines.
abstract: We have tested the hypothesis that adrenomedullin (ADM), a multifunctional peptide hormone, works as a trophoblast proinvasion factor. Our results showed that ADM receptor components-the mRNA and proteins of calcitonin receptor-like receptor (CALCRL) and receptor activity modifying proteins (RAMPs)-were expressed by human choriocarcinoma JAr cells and first-trimester cytotrophoblast HTR-8/SV neo cells. ADM stimulates both JAr and HTR-8/SV neo cell proliferation. The invasion capabilities of JAr cells and HTR-8/SV neo cells were also enhanced by ADM, and this was associated with increased gelatinolytic activity and reduced plasminogen activator inhibitor-1 mRNA expression (SERPINE1). Our data support the notion that ADM may be involved in the human implantation process via regulating trophoblast proliferation and differentiation.
authors.affiliation: Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, 77555, USA.
authors.forename: Xiaoquan
authors.initials: X
authors.lastname: Zhang
authors.forename: Kortney E
authors.initials: KE
authors.lastname: Green
authors.forename: Chandra
authors.initials: C
authors.lastname: Yallampalli
authors.forename: Yuan Lin
authors.initials: YL
authors.lastname: Dong
mesh_terms: D053607:Adrenomedullin; D058286:Calcitonin Receptor-Like Protein; D002460:Cell Line; D049109:Cell Proliferation; D002822:Choriocarcinoma / Q000473:pathology; D005260:Female; D005455:Fluorescent Antibody Technique; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism; D020778:Matrix Metalloproteinase 2 / Q000187:drug effects / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000187:drug effects / Q000378:metabolism; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D010455:Peptides / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D017395:Plasminogen Activator Inhibitor 1 / Q000235:genetics; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D012333:RNA, Messenger / Q000378:metabolism; D058261:Receptor Activity-Modifying Proteins; D058265:Receptors, Adrenomedullin; D018003:Receptors, Calcitonin / Q000235:genetics / Q000378:metabolism; D018000:Receptors, Peptide / Q000235:genetics; D014327:Trophoblasts / Q000166:cytology* / Q000187:drug effects; D014594:Uterine Neoplasms / Q000473:pathology
chemical_list: C545578:CALCRL protein, human; D058286:Calcitonin Receptor-Like Protein; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D010455:Peptides; D017395:Plasminogen Activator Inhibitor 1; D012333:RNA, Messenger; D058261:Receptor Activity-Modifying Proteins; D058265:Receptors, Adrenomedullin; D018003:Receptors, Calcitonin; D018000:Receptors, Peptide; C051321:SERPINE1 protein, human; D053607:Adrenomedullin; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9